Steady-state Pharmacokinetics of Ceftazidime/Avibactam in CF
Latest Information Update: 28 Nov 2018
Price :
$35 *
At a glance
- Drugs Avibactam/ceftazidime (Primary)
- Indications Cystic fibrosis
- Focus Pharmacokinetics
- 24 Oct 2016 Status changed from not yet recruiting to completed.
- 25 Jul 2015 New trial record